OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4761-4761
Open Access | Times Cited: 22
Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4761-4761
Open Access | Times Cited: 22
Showing 22 citing articles:
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways
Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154411-154411
Closed Access | Times Cited: 54
Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154411-154411
Closed Access | Times Cited: 54
Enhancer zeste homolog 2 (EZH2) targeting by small interfering RNA (siRNA); recent advances and prospect
Chou‐Yi Hsu, Ahmed Mohammed, Ahmed Hjazi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Chou‐Yi Hsu, Ahmed Mohammed, Ahmed Hjazi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumors and potential therapeutic agents (Review)
Ziqing Zhan, Xia Luo, Jiaxin Shi, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-15
Open Access
Ziqing Zhan, Xia Luo, Jiaxin Shi, et al.
Experimental and Therapeutic Medicine (2025) Vol. 29, Iss. 4, pp. 1-15
Open Access
Small molecules targeting selected histone methyltransferases (HMTs) for cancer treatment: Current progress and novel strategies
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 13
Deping Li, Xiaopeng Peng, Zhihao Hu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115982-115982
Closed Access | Times Cited: 13
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
Dino Bekric, Daniel Neureiter, Celina Ablinger, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1569-1569
Open Access | Times Cited: 11
Dino Bekric, Daniel Neureiter, Celina Ablinger, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1569-1569
Open Access | Times Cited: 11
EZH2 Expression in Head-and-Neck Squamous Cell Cancer in Young Patients
Mónika Révész, Ferenc Oberna, András Slezák, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5250-5250
Open Access | Times Cited: 2
Mónika Révész, Ferenc Oberna, András Slezák, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5250-5250
Open Access | Times Cited: 2
H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets
Liliana Burlibașa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
Liliana Burlibașa, Alina-Teodora Nicu, Mariana Carmen Chifiriuc, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors
Helena Estevão‐Pereira, Catarina Guimarães‐Teixeira, Bianca C. T. Flores, et al.
Andrology (2024)
Closed Access | Times Cited: 1
Helena Estevão‐Pereira, Catarina Guimarães‐Teixeira, Bianca C. T. Flores, et al.
Andrology (2024)
Closed Access | Times Cited: 1
Combined inhibition of EZH2 and CDK4/6 perturbs endoplasmic reticulum-mitochondrial homeostasis and increases antitumor activity against glioblastoma
Thomas Freitag, Philipp Kaps, Justus Ramtke, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Thomas Freitag, Philipp Kaps, Justus Ramtke, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma
MHD Ouis Al Khatib, Giulia Pinton, Laura Moro, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1537-1537
Open Access | Times Cited: 3
MHD Ouis Al Khatib, Giulia Pinton, Laura Moro, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1537-1537
Open Access | Times Cited: 3
Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients
Berenice Cuevas-Estrada, Michel Montalvo-Casimiro, Paulina Munguía-Garza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7873-7873
Open Access | Times Cited: 2
Berenice Cuevas-Estrada, Michel Montalvo-Casimiro, Paulina Munguía-Garza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7873-7873
Open Access | Times Cited: 2
Epigenetic Alterations as an Adaptive Response to Chemotherapy
Rubiada, Kaneez Fatima, Iqra Mushtaq, et al.
(2024), pp. 215-241
Closed Access
Rubiada, Kaneez Fatima, Iqra Mushtaq, et al.
(2024), pp. 215-241
Closed Access
Mechanistic Insights into Cisplatin Response in Breast Tumors: Molecular Determinants and Drug/Nanotechnology-Based Therapeutic Opportunities
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108513-108513
Closed Access
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Mutation Research/Reviews in Mutation Research (2024) Vol. 794, pp. 108513-108513
Closed Access
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish Khan, Christine Powell, et al.
Research Square (Research Square) (2024)
Open Access
Doha Shokry, Mehwish Khan, Christine Powell, et al.
Research Square (Research Square) (2024)
Open Access
Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B
Doha Shokry, Mehwish Khan, Christine Powell, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Doha Shokry, Mehwish Khan, Christine Powell, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access
Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022
Sindy Cabarca, Carmen Ili, Carlos A. Vanegas, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Sindy Cabarca, Carmen Ili, Carlos A. Vanegas, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
The Epigenetic Landscape of Breast Cancer, Metabolism, and Obesity
Ashley Townsel, Maya Jaffe, Yifei Wu, et al.
Advances in experimental medicine and biology (2024), pp. 37-53
Closed Access
Ashley Townsel, Maya Jaffe, Yifei Wu, et al.
Advances in experimental medicine and biology (2024), pp. 37-53
Closed Access
The Overview: Role of Enhancer of Zeste Homolog 2 in Gastric Cancer Progression and Chemotherapy Resistance
Nalan Gülşen Ünal, Leila Sabour Takanlou, Maryam Sabour Takanlou, et al.
Journal of Enterocolitis (2023) Vol. 1, Iss. 3, pp. 52-55
Open Access | Times Cited: 1
Nalan Gülşen Ünal, Leila Sabour Takanlou, Maryam Sabour Takanlou, et al.
Journal of Enterocolitis (2023) Vol. 1, Iss. 3, pp. 52-55
Open Access | Times Cited: 1
EZH2-regulated PARP-1 Expression is a Likely Mechanism for the Chemoresistance of Gliomas to Temozolomide
Qiang Liang, Bing Wang, Chenran Zhang, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 328-339
Closed Access | Times Cited: 1
Qiang Liang, Bing Wang, Chenran Zhang, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 328-339
Closed Access | Times Cited: 1
A glimpse into let-7e roles in human disorders; friend or foe?
Shadia Hamoud Alshahrani, Triani Yuliastanti, F. Al-dolaimy, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154992-154992
Closed Access | Times Cited: 1
Shadia Hamoud Alshahrani, Triani Yuliastanti, F. Al-dolaimy, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 154992-154992
Closed Access | Times Cited: 1
"Macrophage-Derived Exosomes in Tumor Progression and as Promising Tools for Cancer Therapy"
Jian Wu
Biomedical Journal of Scientific & Technical Research (2023) Vol. 52, Iss. 5
Open Access | Times Cited: 1
Jian Wu
Biomedical Journal of Scientific & Technical Research (2023) Vol. 52, Iss. 5
Open Access | Times Cited: 1
La epigenética y el cáncer
Scarlett Ivonne Ortiz Zamora, Renato Nieto-Aguilar, Alfonso Characu Rueda Rocha, et al.
Ciencia Nicolaita (2023), Iss. 89
Open Access
Scarlett Ivonne Ortiz Zamora, Renato Nieto-Aguilar, Alfonso Characu Rueda Rocha, et al.
Ciencia Nicolaita (2023), Iss. 89
Open Access
Unlocking DNA Damage Sensitivity of Cancer Cells: The Potential of Splicing Inhibitors
Ksenia S. Anufrieva, Maria M. Lukina, O.M. Ivanova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ksenia S. Anufrieva, Maria M. Lukina, O.M. Ivanova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
